01-06-2009 | Interuniversity Cardiology Institute of the Netherlands
The Caveats of drug-eluting stents – a critical appraisal of the safety concerns
Gepubliceerd in: Netherlands Heart Journal | Uitgave 6/2009
Log in om toegang te krijgenAbstract
Pivotal randomised controlled trials and registries showed that both sirolimus- and paclitaxel-eluting stents proved to be superior to bare metal stents at one year of follow-up in selected patients. The present thesis aims to provide insights into the long-term safety, efficacy and caveats of drug-eluting stents.